Canada’s OccuLogix Inc., whose products treat eye diseases, said on Friday it is planning to raise as much as $100 million in an initial public offering of common stock.
Canada’s OccuLogix Inc., whose products treat eye diseases, said on Friday it is planning to raise as much as $100 million in an initial public offering of common stock.
